NOT-GM-26-005: Notice of Early Expiration of PAR-25-202 "Technology Development Research for Establishing Feasibility and Proof of Concept (R21

Notice of Early Expiration of PAR-25-202 "Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)"

Notice Number:

NOT-GM-26-005

Key Dates

Release Date:

May 12, 2026

Related Announcements

November 14, 2025 - Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed). See NOFO PAR-25-202.

Issued by

National Institute of General Medical Sciences (NIGMS)

Purpose

The purpose of this Notice is to inform applicants of the early expiration of PAR-25-202 “Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)” effective immediately. No further applications will be accepted for this NOFO.

Inquiries

Please direct all inquiries to:

NIGMS Technology Development Programs
Email: [email protected]